Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours — Authors' reply

Publikation: Bidrag til tidsskriftKommentar/debatForskningfagfællebedømt

Standard

Letter : be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours — Authors' reply. / Dahl, Emilie; Abed, Osama; Agnholt, Jørgen; Bjerrum, Jacob; Dige, Anders; Kjeldsen, Jens; Svane, Inge; Donia, Marco; Seidelin, Jakob.

I: Alimentary Pharmacology and Therapeutics, Bind 57, Nr. 8, 2023, s. 918-919.

Publikation: Bidrag til tidsskriftKommentar/debatForskningfagfællebedømt

Harvard

Dahl, E, Abed, O, Agnholt, J, Bjerrum, J, Dige, A, Kjeldsen, J, Svane, I, Donia, M & Seidelin, J 2023, 'Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours — Authors' reply', Alimentary Pharmacology and Therapeutics, bind 57, nr. 8, s. 918-919. https://doi.org/10.1111/apt.17431

APA

Dahl, E., Abed, O., Agnholt, J., Bjerrum, J., Dige, A., Kjeldsen, J., Svane, I., Donia, M., & Seidelin, J. (2023). Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours — Authors' reply. Alimentary Pharmacology and Therapeutics, 57(8), 918-919. https://doi.org/10.1111/apt.17431

Vancouver

Dahl E, Abed O, Agnholt J, Bjerrum J, Dige A, Kjeldsen J o.a. Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours — Authors' reply. Alimentary Pharmacology and Therapeutics. 2023;57(8):918-919. https://doi.org/10.1111/apt.17431

Author

Dahl, Emilie ; Abed, Osama ; Agnholt, Jørgen ; Bjerrum, Jacob ; Dige, Anders ; Kjeldsen, Jens ; Svane, Inge ; Donia, Marco ; Seidelin, Jakob. / Letter : be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours — Authors' reply. I: Alimentary Pharmacology and Therapeutics. 2023 ; Bind 57, Nr. 8. s. 918-919.

Bibtex

@article{749b2fb1829b49fe829c3d28bafeb848,
title = "Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours — Authors' reply",
keywords = "Humans, Gastrointestinal Diseases, Neoplasms/drug therapy, Communicable Diseases, Cytomegalovirus Infections/diagnosis",
author = "Emilie Dahl and Osama Abed and J{\o}rgen Agnholt and Jacob Bjerrum and Anders Dige and Jens Kjeldsen and Inge Svane and Marco Donia and Jakob Seidelin",
note = "Funding Information: Declaration of personal interests: The authors' declarations of personal and financial interests are unchanged from those in the original article.6",
year = "2023",
doi = "10.1111/apt.17431",
language = "English",
volume = "57",
pages = "918--919",
journal = "Alimentary Pharmacology and Therapeutics, Supplement",
issn = "0953-0673",
publisher = "Wiley-Blackwell",
number = "8",

}

RIS

TY - JOUR

T1 - Letter

T2 - be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours — Authors' reply

AU - Dahl, Emilie

AU - Abed, Osama

AU - Agnholt, Jørgen

AU - Bjerrum, Jacob

AU - Dige, Anders

AU - Kjeldsen, Jens

AU - Svane, Inge

AU - Donia, Marco

AU - Seidelin, Jakob

N1 - Funding Information: Declaration of personal interests: The authors' declarations of personal and financial interests are unchanged from those in the original article.6

PY - 2023

Y1 - 2023

KW - Humans

KW - Gastrointestinal Diseases

KW - Neoplasms/drug therapy

KW - Communicable Diseases

KW - Cytomegalovirus Infections/diagnosis

U2 - 10.1111/apt.17431

DO - 10.1111/apt.17431

M3 - Comment/debate

C2 - 36952273

AN - SCOPUS:85150815100

VL - 57

SP - 918

EP - 919

JO - Alimentary Pharmacology and Therapeutics, Supplement

JF - Alimentary Pharmacology and Therapeutics, Supplement

SN - 0953-0673

IS - 8

ER -

ID: 341495236